Compensation Information for Named Executive Officers (February 25th, 2016)
Compensation Information for Named Executive Officers (March 2nd, 2015)
2013 Bonus and 2014 Compensation Information for Named Executive Officers (February 27th, 2014)
Andrew Wolff, Sr. Vice President, Clinical Research and Development and Chief Medical Officer: base salary $388,000; 2013 bonus award $108,640; 2014 target bonus 35% of salary.
2012 Bonus and 2013 Compensation Information for Named Executive Officers (March 11th, 2013)
March __, 2009 [Name] [Title] Cytokinetics, Incorporated 280 East Grand Ave. South San Francisco, CA 94080 Re: Amendment No. 1 to Amended and Restated Executive Employment Agreement Dear , (March 12th, 2009)
As you know, Cytokinetics, Incorporated (the Company) and you (Executive) are parties to that certain Amended and Restated Executive Employment Agreement effective [date] (the Agreement). By this letter amendment, the parties agree to amend the Agreement as described below in order to comply with Internal Revenue Code Section 409A, effective as of January 1, 2009:
Cytokinetics, Incorporated Executive Employment Agreement (March 10th, 2006)
This Executive Employment Agreement (the Agreement) is made and entered into by and between David Cragg (the Executive) and Cytokinetics, Incorporated, a Delaware Corporation (the Company), effective as of February 1, 2005 (the Effective Date).